Articles from Palomino Laboratories Inc

Palomino Laboratories Inc. Ships First Generation MicroLED Light Engine Prototypes to First Hyperscaler Customer
Announcement Highlights:
By Palomino Laboratories Inc · Via GlobeNewswire · July 22, 2026
Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company
Transaction Highlights: 
By Palomino Laboratories Inc · Via GlobeNewswire · July 16, 2026
Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET
Common stock begins trading on the OTCQB under the symbol "PALX" effective July 10, 2026; Company continues development of its core optical technologies focused on moving data faster and more efficiently in AI data centers
By Palomino Laboratories Inc · Via GlobeNewswire · July 13, 2026
Palomino Laboratories Inc. Co-Founder, Dr. Steven P. DenBaars, Receives the Prestigious 2026 IEEE Nick Holonyak Jr. Award at IEEE 2026 Honors Ceremony
PALO ALTO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Palomino Laboratories Inc. (OTCQB: PALX) proudly announces that its Co-Founder, Dr. Steven P. DenBaars, has been honored with the 2026 IEEE Nick Holonyak Jr. Medal. The award was presented last Friday, April 25th, 2026, at the esteemed IEEE 2026 Honors Ceremony in New York City, recognizing Dr. DenBaars for his pioneering contributions to compound semiconductor optoelectronics. His novel research includes advancements in high-efficiency visible light-emitting diodes (LEDs), lasers, and LED displays.
By Palomino Laboratories Inc · Via GlobeNewswire · April 28, 2026
Palomino Laboratories Inc. Closes $15 Million at $4/share
PALO ALTO, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Palomino Laboratories Inc. (OTCQB: PALX) (the “Company”), an optical data communications technology company developing a way to move data faster and more efficiently using light from GaN-based MicroLEDs instead of traditional copper wires, is pleased to announce that it has raised $15,095,412 in a private placement offering. In the offering, the Company sold 3,773,853 shares of its common stock at a purchase price of $4.00 per share.
By Palomino Laboratories Inc · Via GlobeNewswire · April 27, 2026
Articles from Palomino Laboratories Inc | Hannibal Courier - Post